Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Natco Pharma LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:524816NSE Symbol: NATCOPHARMP/E(TTM):10.69
ISIN Demat:INE987B01026Div & Yield %:0.66EPS(TTM):84.75
Book Value(Rs):461.79599Market Cap ( Cr.):16229.15Face Value(Rs):2
    Change Company 
Date Headline
02-Dec-25 Natco Pharma announces change in senior management
29-Nov-25 Natco Pharma receives affirmation in credit ratings from ICRA
27-Nov-25 Whirlpool of India Ltd leads losers in 'A' group
26-Nov-25 Volumes soar at Carborundum Universal Ltd counter
26-Nov-25 Carborundum Universal Ltd leads gainers in 'A' group
24-Nov-25 Natco Pharma slides after receiving seven USFDA observations for Chennai API plant
21-Nov-25 Natco Pharma concludes USFDA inspection of its API unit in Chennai
20-Nov-25 Volumes jump at Radico Khaitan Ltd counter
14-Nov-25 Board of Natco Pharma recommends interim dividend
14-Nov-25 Natco Pharma fixes record date for interim dividend
<< < 1 2 3 4   > >>